Opinion ID: 212733
Heading Depth: 3
Heading Rank: 1

Heading: The NC-Stat

Text: NeuroMetrix manufactured and marketed a signature product during the class period, a machine called the NC-Stat. The NC-Stat is a device that permits non-invasive nerve conduction studies to detect[], diagnos[e], and monitor[] neurological conditions affecting the peripheral nerves. R.32 at 2. The NC-Stat is comprised of a battery-operated hand-held device and disposable single-use biosensors that are placed on the patient's body ... to detect neuropathies. Id. at 11. The device was marketed to provide primary care and specialist physicians with the ability to rapidly diagnose neuropathies in the physician's office at the time the patient is examined. Id. at 12. Prior to the introduction of the NC-Stat, the prevailing standard technology for neurological studies for these conditions was electromyography (EMG), an invasive, needle-based test performed by neurologists. The NC-Stat sold for about $5,000 and the disposable biosensors for roughly $35 a piece. The bulk of the profit to NeuroMetrix came through the sale of the biosensors. The device was marketed as providing non-specializing physicians, who traditionally could not perform diagnostic tests in this field, with a sustainable source of revenue.